18
Disclaimer
is pocket card is derived om recommendations in the American Society of Clinical Oncology
Guideline. is resource is a practice tool based on ASCO
®
practice guidelines and is not
intended to substitute for the independent professional judgment of the treating physician.
Practice guidelines do not account for individual variation among patients. is pocket card
does not purport to suggest any particular course of medical treatment. Use of the practice
guidelines and this resource are voluntary. e practice guidelines and additional information
are available at www.asco.org/supportive-care-guidelines. Copyright © 2017 by American
Society of Clinical Oncology. All rights reserved.
Source
Hesketh PJ et al. Antiemetics: American Society of Clinical Oncolog y Clinical Practice
Guideline Update. J Clin Oncol. 2017 July 31; doi:10.1200/JCO.2017.74.4789
Abbreviations
AUC, area under the curve; 5-HT
3
, 5-hydroxytryptamine-3; IV, intravenous; NK
1
,
neurokinin 1
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2017 All rights reserved
ASCOANT1773
Recommendation Grading
Type Evidence Quality
Strength Of
Recommendation
EB Evidence-based H High Strong
IC Informal consensus I Intermediate Moderate
L Low Weak
ASCO believes that cancer clinical trials are vital to inform medical decisions and
improve cancer care and that all patients should have the opportunity to participate.
Additional information, which may include data supplements, slide sets, patient
versions, frequently asked questions, and other clinical tools and resources, is available at
www.asco.org/supportive-care-guidelines and www.asco.org/guidelineswiki